Janssen Research & Development, Raritan, NJ – FDA Inspections

Inspection records and compliance data for Janssen Research & Development in Raritan, New Jersey. 3 FDA inspections on record, last inspected March 01, 2023.

Company Profile

This profile covers Janssen Research & Development based in Raritan, New Jersey, United States.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 1
NAI: 2
Form 483s: 0
Warning letters: 0

First inspected March 26, 2015. Last inspected March 1, 2023.

Most cited issue areas

Ensuring compliance with plan and protocol1 inspection
General responsibilities of sponsors1 inspection

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
March 1, 2023	NAI	Human Drugs · Bioresearch Monitoring	1200327
July 30, 2015	NAI	Human Drugs · Bioresearch Monitoring	936659
March 26, 2015	VAI	Human Drugs · Bioresearch Monitoring	922964

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Main Line Medical Supplies Inc.

Hassman Research Institute

Missha US, Inc.

Micro Chem Laboratories

Par Sterile Products LLC DBA JHP Pharmaceuticals, LLC

Johnson & Johnson Pharmaceutical Research & Development, LLC

Actavis Totowa LLC

Oxygen Supply Company, Inc.

Complete Analysis Laboratories Inc

Optimer Pharmaceuticals